Zhang, Linwei
McFarland, Karen N.
Subramony, S . H.
Heilman, Kenneth M.
Ashizawa, Tetsuo
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS083564)
National Institute on Aging (AG044449)
Article History
First Online: 24 August 2016
Change Date: 27 November 2017
Change Type: Correction
Change Details: The original version of this article unfortunately contained an incorrect assignment of affiliations of Linwei Zhang and Tetsuo Ashizawa.
Compliance with Ethical Standards
: Samples were collected under a protocol approved by the University of Florida’s Institutional Review Board (IRB) and following informed consent.
: Drs. Zhang and McFarland report no disclosures.Dr. Subramony receives research support from IONIS (previously ISIS) Pharmaceuticals, REATA Pharmaceuticals and Horizon Pharmaceuticals.Dr. Heilman receives a grant from NIH #AG044449 and a contract from the Department of Elder Affairs of the State of Florida.Dr. Ashizawa has received grants from IONIS (previously ISIS) Pharmaceuticals, the Myotonic Dystrophy Foundation and the Muscular Dystrophy Association. Dr. Ashizawa receives a grant from NIH (#NS083564) and received an honorarium for serving as a consultant for BioHaven Pharmaceuticals.